Skip to main content
SpringerLink
Log in

Cardiac safety of nilotinib assessed

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Larson RA, Hochhaus A, Saglio G, Rosti G, Lopez JL, Stenke L, Nakamae H, Goldberg SL, Wang M-C, Gallagher NJ, Hoenekopp A, Ortmann C-E, Hughes TP, Kantarjian HM.Cardiac Safety Profile of Imatinib and Nilotinib In Patients (pts) with Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP): Results From ENESTnd. 52nd Annual Meeting and Exposition of the American Society of Hematology: abstr. 2291, 4 Dec 2010. Available from: URL: http://www.hematology.org

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cardiac safety of nilotinib assessed. React. Wkly. 1331, 3 (2010). https://doi.org/10.2165/00128415-201013310-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013310-00005

Keywords

Search

Navigation